Elian Dupre
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Tanycytic degeneration impairs tau clearance and contributes to Alzheimer's disease pathology.
Journal: Cell press blue
Published: May 25, 2026
A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of Tau.
Journal: ACS chemical neuroscience
Published: May 08, 2026
A new chemotype that opens the S2∗ pocket of the 3CL protease exhibits antiviral activity against SARS-CoV-2.
Journal: European journal of medicinal chemistry
Published: October 01, 2025
Tau profiling of brain extracellular vesicles reveals PHF6 peptide as core for pathological tau seeding in Alzheimer's disease.
Journal: Journal of biomedical science
Published: August 25, 2025
Anti-tau VHH therapy against PHF6: a safe approach to slowing the phenotype of tau pathology.
Journal: Alzheimer's research & therapy
Published: May 15, 2025
Aggregate-selective removal of pathological tau by clustering-activated degraders.
Journal: Science (New York, N.Y.)
Published: August 29, 2024
Inhibition of tau neuronal internalization using anti-tau single domain antibodies.
Journal: Nature communications
Published: July 16, 2024
Recombinant Production and Characterization of VHHs/Nanobodies Targeting Tau to Block Fibrillar Assembly.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 21, 2024
Magnetic resonance investigation of conformational responses of tau protein to specific phosphorylation.
Journal: Biophysical chemistry
Published: July 23, 2023
A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein.
Journal: The Journal of biological chemistry
Published: July 19, 2023
Conformation and Affinity Modulations by Multiple Phosphorylation Occurring in the BIN1 SH3 Domain Binding Site of the Tau Protein Proline-Rich Region.
Journal: Biochemistry
Published: May 11, 2023
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.
Journal: European journal of medicinal chemistry
Published: December 05, 2022
Last Updated: 09/26/2026